GENZYME CORP
DelistedCIK 732485fmd_0DPNRGZS9568QWR68YWNZ0HFC3Manufacturing · Biological Products, (No Diagnostic Substances)Template: Standard
Coverage: Jan 01, 2007 to Dec 31, 2010, 12 periods
Latest annual · FY2010
Millions- Total revenues
- 4,049
- Gross profit
- 2,895
- Operating income
- 36
- Net income
- 422
- Free cash flow
- (167)
Latest quarter · Q4 FY2010
Millions- Total revenues
- 1,152
- Gross profit
- 816
- Operating income
- 108
- Net income
- 472
- Free cash flow
- (233)
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2007 to FY2010
- +2.0%
GENZYME CORP financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2010 | FY2009 | Change | Source |
|---|---|---|---|---|
| Revenue | $4 billion | $4 billion | +1.8% | 10-K 2011-03-01 · proof |
| Gross profit | $2.9 billion | $2.9 billion | -1.4% | 10-K 2011-03-01 · proof |
| Operating income | $35.8 million | $509.6 million | -93% | 10-K 2011-03-01 · proof |
| Net income | $422.1 million | $422.3 million | 0% | 10-K 2011-03-01 · proof |
| Cash from operating activities | $487 million | $1.2 billion | -58.7% | 10-K 2011-03-01 · proof |
| Free cash flow | -$167.1 million | $517.3 million | -132.3% | 10-K 2011-03-01 · proof |
| Total assets | $10.9 billion | $10.1 billion | +8.5% | 10-K 2011-03-01 · proof |
| Total liabilities | $3.3 billion | $2.4 billion | +40% | 10-K 2011-03-01 · proof |
| Cash and cash equivalents | $1.3 billion | $742.2 million | +79.3% | 10-K 2011-03-01 · proof |
| Total debt | $1.1 billion | $124.6 million | +788.1% | 10-K 2011-03-01 · proof |
- What was GENZYME CORP's revenue in fiscal 2010?
- GENZYME CORP reported revenue of $4 billion for fiscal 2010 (the year ended Dec 31, 2010), against $4 billion the year before (+1.8%). Source: the 10-K filed with the SEC on Mar 1, 2011. SEC
- What was GENZYME CORP's gross profit in fiscal 2010?
- GENZYME CORP reported gross profit of $2.9 billion for fiscal 2010 (the year ended Dec 31, 2010), against $2.9 billion the year before (-1.4%). Source: the 10-K filed with the SEC on Mar 1, 2011. SEC
- What was GENZYME CORP's operating income in fiscal 2010?
- GENZYME CORP reported operating income of $35.8 million for fiscal 2010 (the year ended Dec 31, 2010), against $509.6 million the year before (-93%). Source: the 10-K filed with the SEC on Mar 1, 2011. SEC
- What was GENZYME CORP's net income in fiscal 2010?
- GENZYME CORP reported net income of $422.1 million for fiscal 2010 (the year ended Dec 31, 2010), against $422.3 million the year before (0%). Source: the 10-K filed with the SEC on Mar 1, 2011. SEC
- What was GENZYME CORP's cash from operating activities in fiscal 2010?
- GENZYME CORP reported cash from operating activities of $487 million for fiscal 2010 (the year ended Dec 31, 2010), against $1.2 billion the year before (-58.7%). Source: the 10-K filed with the SEC on Mar 1, 2011. SEC
- What was GENZYME CORP's free cash flow in fiscal 2010?
- GENZYME CORP reported free cash flow of -$167.1 million for fiscal 2010 (the year ended Dec 31, 2010), against $517.3 million the year before (-132.3%). Source: the 10-K filed with the SEC on Mar 1, 2011. SEC
- What are GENZYME CORP's total assets?
- As of Dec 31, 2010, GENZYME CORP reported total assets of $10.9 billion, against $10.1 billion a year earlier (+8.5%). Source: the 10-K filed with the SEC on Mar 1, 2011. SEC
- What are GENZYME CORP's total liabilities?
- As of Dec 31, 2010, GENZYME CORP reported total liabilities of $3.3 billion, against $2.4 billion a year earlier (+40%). Source: the 10-K filed with the SEC on Mar 1, 2011. SEC
- What are GENZYME CORP's cash and cash equivalents?
- As of Dec 31, 2010, GENZYME CORP reported cash and cash equivalents of $1.3 billion, against $742.2 million a year earlier (+79.3%). Source: the 10-K filed with the SEC on Mar 1, 2011. SEC
- What is GENZYME CORP's total debt?
- As of Dec 31, 2010, GENZYME CORP reported total debt of $1.1 billion, against $124.6 million a year earlier (+788.1%). Source: the 10-K filed with the SEC on Mar 1, 2011. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:732485&period_type=annual&limit=5"Information only, not investment advice.